Pacific Biosciences of California Inc Shares Close the Week 20.7% Lower - Weekly Wrap

The company saw its shares close the week 20.7% lower than last week, with trading volume higher than its 30 day average.

Jan 12, 2022 by Kwhen Finance Editors

Pacific Biosciences of California Inc Shares Close the Week 20.7% Lower - Weekly Wrap
Pacific Biosciences of California Inc (PACB) shares closed this week 20.7% lower than it did at the end of last week. The stock is currently down 19.0% year-to-date, down 54.8% over the past 12 months, and up 230.9% over the past five years. This week, the Dow Jones Industrial Average fell 1.3%, and the S&P 500 fell 2.6%.

Trading Activity

  • Shares traded as high as $21.01 and as low as $15.58 this week.
  • Trading volume this week was 10.6% higher than the 10-day average and 38.2% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 2.7.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed above its Bollinger band, indicating it may be overbought.

Market Comparative Performance

  • The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Pacific Biosciences of California Inc-2.4-19.0-54.8
Dow Jones Industrial Average0.5-0.718.0-2.422.8
S&P 500 Index0.9-2.023.7-3.128.0
Health Care0.8-4.314.2-4.722.4

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by 154.1%
  • The company's stock price performance over the past 12 months lags the peer average by 556.1%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Pacific Biosciences of California IncPACB-99.0-19.0-54.8
Peer AvgN/A-25.7-7.5-8.4-5.119.2
Thermo Fisher Scientific Inc.TMO28.8-6.322.3-7.044.5
General Electric Co.GE-262.45.29.9-13.618.2
Illumina IncILMN62.5-4.8-4.6
Perkinelmer, Inc.PKI20.5-8.615.2-9.952.8
Nanostring Technologies IncNSTG0-11.4-43.3
Fluidigm CorpFLDM-3.6-18.9-49.7

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: